Graphene Oxide-Based Nanocarriers for Cancer Imaging and Drug Delivery

Author(s): Peihong You, Yang Yang, Mingwei Wang, Xiaoyu Huang, Xiao Huang

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 22 , 2015

Become EABM
Become Reviewer
Call for Editor


Nano graphene oxide (nGO) is a member of graphene family, which is a novel, one-atom-thickness, two-dimensional carbon nanomaterial. In comparison with graphene, nGO contains much higher extent of reactive chemical functionalities such as hydroxyl, carbonyl, carboxyl, and epoxy group, so as to enable its easier biochemo-functionalization, higher biocompatibility, and greater potentials of applications in biomedicine fields. Up to now, nGO has attracted extensive research interests in nanomedicine and drug delivery systems for cancer imaging and therapy due to its unique biochemical and in vivo properties. This review generally describes the preparation, functionalization, and toxicity of nGO firstly, and then focuses on the studies of biomedical applications for cancer imaging and drug delivery.

Keywords: Cancer imaging, drug delivery, graphene oxide, nanocarrier.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 31 May, 2015
Page: [3215 - 3222]
Pages: 8
DOI: 10.2174/1381612821666150531170832
Price: $65

Article Metrics

PDF: 31